rs142726511
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4BP7
This summary comes from the ClinGen Evidence Repository: The c.282C>T p.Gly94= variant in UBE3A (NM_130838.2) is present in gnomAD v2.1.1 at a frequency of 0.0069% in the European (non-Finnish) sub population (no criteria met). The silent p.Gly94= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7). In summary, the c.282C>T p.Gly94= variant in UBE3A is classified as Likely Benign based on the ACMG/AMP criteria (BP4, BP7). LINK:https://erepo.genome.network/evrepo/ui/classification/CA7435667/MONDO:0007113/032
Frequency
Consequence
NM_130839.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBE3A | NM_130839.5 | c.342C>T | p.Gly114= | synonymous_variant | 5/13 | ENST00000648336.2 | NP_570854.1 | |
SNHG14 | NR_146177.1 | n.18393-16112G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBE3A | ENST00000648336.2 | c.342C>T | p.Gly114= | synonymous_variant | 5/13 | NM_130839.5 | ENSP00000497572 | P1 | ||
SNHG14 | ENST00000656420.1 | n.5457-43304G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152104Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250442Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135682
GnomAD4 exome AF: 0.0000971 AC: 142AN: 1461800Hom.: 0 Cov.: 30 AF XY: 0.0000839 AC XY: 61AN XY: 727188
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152104Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74292
ClinVar
Submissions by phenotype
Angelman syndrome Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 27, 2023 | - - |
Likely benign, reviewed by expert panel | curation | ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel | Jun 15, 2023 | The c.282C>T p.Gly94= variant in UBE3A (NM_130838.2) is present in gnomAD v2.1.1 at a frequency of 0.0069% in the European (non-Finnish) sub population (no criteria met). The silent p.Gly94= variant is not predicted to affect splicing using multiple computational tools and does not affect a highly conserved nucleotide (BP4, BP7). In summary, the c.282C>T p.Gly94= variant in UBE3A is classified as Likely Benign based on the ACMG/AMP criteria (BP4, BP7). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at